PRIVATE CAPITAL INCREASE

• We announced on January 21, 2026, a private capital increase of a minimum of R$ 156 million and a maximum of R$ 214 million
• Controlling shareholders intend to exercise their subscription rights in the amount of R$ 156 million
• Exercise price: R$ 4.35, reflecting a 12.7% discount compared to the weighted average price of the last 10 trading sessions (January 7-20, 2026)
• Subscription ratio of 8.251258595% on the shares of the same type they hold on the record date of January 29, 2026
• Period to exercise the preemptive right: January 30, 2026 (inclusive) to March 2, 2026 (inclusive)
• Allocation of remaining shares and additional remaining shares: will be communicated later by the Bank
• The investor must request the exercise of the preemptive right through your securities brokerage. It is worth emphasizing that buying subscription rights (BMGB2) traded on B3, by itself, does not imply the subscription of shares

For more details, please consult the Material Fact and Notice to Shareholders available by clicking here.

PRIVATE CAPITAL INCREASE

• We announced on January 21, 2026, a private capital increase of a minimum of R$ 156 million and a maximum of R$ 214 million
• Controlling shareholders intend to exercise their subscription rights in the amount of R$ 156 million
• Exercise price: R$ 4.35, reflecting a 12.7% discount compared to the weighted average price of the last 10 trading sessions (January 7-20, 2026)
• Subscription ratio of 8.251258595% on the shares of the same type they hold on the record date of January 29, 2026
• Period to exercise the preemptive right: January 30, 2026 (inclusive) to March 2, 2026 (inclusive)
• Allocation of remaining shares and additional remaining shares: will be communicated later by the Bank
• The investor must request the exercise of the preemptive right through your securities brokerage. It is worth emphasizing that buying subscription rights (BMGB2) traded on B3, by itself, does not imply the subscription of shares